Browsing by Author Tam, CCT

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 10 to 19 of 19 < previous 
TitleAuthor(s)Issue DateViews
 
Personalized Treatment of Lung Adenocarcinoma
Journal:Clinical Pulmonary Medicine
Ho, JCMTam, CCTLam, SK
2013
53
 
Plasma EGFR Mutation Detection Associated With Survival Outcomes in Advanced-Stage Lung Cancer
Journal:Clinical Lung Cancer
Lam, CLDTam, CCTLau, KMWong, WMHui, KMCLam, JCWang, JKLui, MSMHo, JCMIp, MSM
2015
77
 
Progression-free survival among progressed non-small-cell lung cancer with T790M mutation as guided by liquid versus tissue re-biopsy
Proceeding/Conference:24th Medical Research Conference, Department of Medicine, the University of Hong Kong
Kwok, WCHo, JCMLam, CLDLui, MSMIp, MSMTam, CCT
2019
63
 
Risk factors of nephrotoxicity of maintenance pemetrexed in patients with metastatic non-squamous non-small cell carcinoma of lung
Journal:Lung Cancer
Kwok, WCChiang, KYHo, JCMLam, CLDIp, MSMTam, CCT
2021
1
 
Salvage Therapy Beyond Targeted Therapy in Lung Adenocarcinoma
Journal:Seminars in Respiratory and Critical Care Medicine
Ho, JCMTam, CCTLam, SK
2013
52
 
Serum protein level as a predictor of therapeutic response and adverse effects associated with afatinib use
Journal:Journal of Thoracic Disease
Kwok, WCHo, JCMTam, CCTIp, MSMLam, CLD
2022
1
 
Survival benefits from afatinib compared with gefitinib and erlotinib among patients with common EGFR mutation in first‐line setting
Journal:Thoracic Cancer
Kwok, WCHo, JCMTam, CCTIp, MSMLam, CLD
2022
4
 
Territory-wide study on hospital admissions for asthma exacerbations in the COVID-19 pandemic
Journal:Annals of the American Thoracic Society
Chan, FKPKwok, WCMa, TFHui, CHTam, CCTWang, KLJHo, JCMLam, CLDIp, MSMHo, PL
2021
 
Treatment outcomes in elderly with advanced-stage non-small celllung cancer. 17th Congress of the Asia Pacific Society of Respiroogy, Hong Kong
Proceeding/Conference:Respirology
Tam, CCTHo, JCMWong, KYMWong, WMWang, KLJLam, CMJLui, MSMLam, WKIp, MSMLam, CLD
2012
76
 
When compared to plasma-based detection, osimertinib-treated non-small cell lung cancer (NSCLC) with tissue rebiopsy-confirmed acquired T790M mutation is associated with better survival
Journal:Asia-Pacific Journal of Clinical Oncology
Kwok, WCHo, JCMLam, CLDLui, MSMIp, MSMTam, CCT
2021
Showing results 10 to 19 of 19 < previous